HEALTHCARE provider Thomson Medical Group has named Gleneagles Hospital&rsquo s chief executive officer (CEO) Melvin Heng as its executive director and group CEO, with effect from Dec 1.

 

Heng will be succeeding Wong Chiang Yin, who resigned in late August to pursue personal interests after more than two years* into the role. His last day was on Sep 30.

 

According to Thomson Medical&rsquo s filing on Friday (Oct 7) morning, Heng &ndash who has been chief executive at rival IHH Healthcare&rsquo s Gleneagles since the start of 2021 &ndash will continue to serve at his current role until Oct 31 before joining Thomson Medical. 

 

Prior to his appointment as Gleneagles&rsquo CEO, Heng joined the IHH brand in September 2017 as assistant vice-president of operations before taking on the role of chief operating officer in July 2019.

 

Heng was previously a medical adviser at Singapore&rsquo s Ministry of Health from 2016 to 2018. In 2018, he co-founded digital healthcare startup Mesh Bio, where he remains an alternate director. He was listed as a co-founder of Global Medical Concierge from 2013 to 2017.

 

In the earlier years of his career, Heng worked as a medical doctor at the UK&rsquo s National Health Service as well as Singapore&rsquo s Tan Tock Seng Hospital.

 

Heng has an MBBS (Bachelor of Medicine and Bachelor of Surgery) from the University of London, St Georges Hospital a graduate diploma in occupational medicine from the University of Singapore and a Masters of Business Administration from the Frankfurt School of Finance & Management.

 

He is currently listed as a director of a private limited company in Singapore, Astrid Park Capital.